Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gobert

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Pharmacology|August 24, 1993
WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivoF Lejeune, J M Rivet, A Gobert, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 1999
Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivoM J Millan, A Gobert, V Audinot, et al.
Journal of Neurochemistry|December 31, 1997
Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving ratsA Gobert, J M Rivet, L Cistarelli, et al.
Toxicology Letters|June 1, 1994
Neuroendocrine phenotype differentiation in a hamster lung epithelial cell line under low oxygen pressure or after transformation by diethylnitrosamineM Emura, A Ochiai, A Gobert-Bohlen, et al.
Bulletin De La Societe Belge D'Ophtalmologie|January 1, 1995
Ocular perforation in uteroA Gobert, G Vereecken, F Meire, et al.
European Journal of Pharmacology|May 23, 1998
WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortexM J Millan, M Brocco, S Veiga, et al.
European Journal of Pharmacology|November 24, 1994
Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297J M Rivet, V Audinot, A Gobert, et al.
Psychopharmacology|November 10, 2001
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in ratsA Dekeyne, A Gobert, L Iob, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 15, 2001
Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agentM J Millan, M Brocco, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonistsR Schreiber, M Brocco, V Audinot, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Pharmacology|August 24, 1993
WAY 100,135 and (-)-tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivoF Lejeune, J M Rivet, A Gobert, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 5, 1999
Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivoM J Millan, A Gobert, V Audinot, et al.
Journal of Neurochemistry|December 31, 1997
Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving ratsA Gobert, J M Rivet, L Cistarelli, et al.
Toxicology Letters|June 1, 1994
Neuroendocrine phenotype differentiation in a hamster lung epithelial cell line under low oxygen pressure or after transformation by diethylnitrosamineM Emura, A Ochiai, A Gobert-Bohlen, et al.
Bulletin De La Societe Belge D'Ophtalmologie|January 1, 1995
Ocular perforation in uteroA Gobert, G Vereecken, F Meire, et al.
European Journal of Pharmacology|May 23, 1998
WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortexM J Millan, M Brocco, S Veiga, et al.
European Journal of Pharmacology|November 24, 1994
Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297J M Rivet, V Audinot, A Gobert, et al.
Psychopharmacology|November 10, 2001
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in ratsA Dekeyne, A Gobert, L Iob, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 15, 2001
Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists, CP154,526 and DMP695: a comparison to other classes of anxiolytic agentM J Millan, M Brocco, A Gobert, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonistsR Schreiber, M Brocco, V Audinot, et al.
Pageof 8